Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials

Journal of Critical Care

Volumn 40, Issue , 2017, Pages 21-30

  Alquraini, Mustafa ^a   Alshamsi, Fayez ^a,b   Møller, Morten Hylander ^c   Belley Cote, Emilie ^a   Almenawer, Saleh ^a   Jaeschke, Roman ^a   MacLaren, Robert ^d   Alhazzani, Waleed ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Critical illness; Histamine 2 receptor antagonists; Meta analysis; Stress ulcer; Sucralfate; Systematic review

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; SUCRALFATE; ANTIULCER AGENT;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CRITICALLY ILL PATIENT; DRUG EFFICACY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LENGTH OF STAY; META ANALYSIS; OUTCOME ASSESSMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEQUENTIAL ANALYSIS; STRESS ULCER; CRITICAL ILLNESS; PNEUMONIA; STOMACH ULCER;

ADULT; ANTI-ULCER AGENTS; CRITICAL ILLNESS; HISTAMINE H2 ANTAGONISTS; HUMANS; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH ULCER; SUCRALFATE;

EID: 85020729889     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.03.005     Document Type: Article

References (48)

1. Lucas, C.E., Sugawa, C., Riddle, J., Rector, F., Rosenberg, B., Walt, A.J., Natural history and surgical dilemma of “stress” gastric bleeding. Arch Surg 102:4 (1971), 266–273.
2. Choung, R.S., Talley, N.J., Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med 8:4 (2008), 253–257.
3. Heyland, D., Gafni, A., Griffith, L., Cook, D., Marshall, J., Fuller, H., et al. The clinical and economic consequences of clinically important gastro-intestinal bleeding in critically ill patients. Clin Intensive Care 7 (1996), 121–125.
4. Cook, D.J., Griffith, L.E., Walter, S.D., Guyatt, G.H., Meade, M.O., Heyland, D.K., et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5:6 (2001), 368–375.
5. Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:2 (2013), 165–228.
6. Krag, M., Perner, A., Wetterslev, J., Wise, M.P., Hylander, Møller M., Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 40:1 (2014), 11–22.
7. MacLaren, R., Reynolds, P.M., Allen, R.R., Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 174:4 (2014), 564–574.
8. Cook, D., Guyatt, G., Marshall, J., Leasa, D., Fuller, H., Hall, R., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian critical care trials group. N Engl J Med 338:12 (1998), 791–797.
9. Krag, M., Perner, A., Wetterslev, J., Wise, M.P., Borthwick, M., Bendel, S., et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 41:5 (2015), 833–845.
10. Huang, J., Cao, Y., Liao, C., Wu, L., Gao, F., Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit Care, 14(5), 2010, R194.
11. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:4 (2009), 264–269.
12. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
13. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
14. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
15. Schünemann, H.J., Oxman, A.D., Vist, G.E., JPT, Higgins, Deeks, J.J., Glasziou, P., et al. Chapter 12: interpreting results and drawing conclusions. JPT, Higgins, Green, S., (eds.) Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org.
16. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315:7109 (1997), 629–634.
17. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C., Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:1 (2008), 64–75.
18. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C., Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol, 9, 2009, 86.
19. Higgins, J., Whitehead, A., Simmonds, M., Sequential methods for random-effects meta-analysis. Stat Med 30:9 (2011), 903–921.
20. Pogue, J., Yusuf, S., Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 351:9095 (1998), 47–52.
21. Ben-Menachem, T., Fogel, R., Patel, R.V., Touchette, M., Zarowitz, B.J., Hadzijahic, N., et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized, controlled, single-blind study. Ann Intern Med 121:8 (1994), 568–575.
22. Bhanot, R.D., Nosocomial pneumonia in mechanically ventilated patients receiving ranitidine, omeprazole or sucralfate as stress ulcer prophylaxis. Am J Respir Crit Care Med, 181, 2010.
23. Cannon, L.A., Heiselman, D., Gardner, W., Jones, J., Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. A randomized study comparing the efficacy of sucralfate, cimetidine, and antacids. Arch Intern Med 147:12 (1987), 2101–2106.
24. Darlong, V., Jayalakhsmi, T.S., Kaul, H.L., Tandon, R., Stress ulcer prophylaxis in patients on ventilator. Trop Gastroenterol 24:3 (2003), 124–128.
25. Azevedo, J.R., Soares, M.G., Silva, G., Palacio, G., Prevention of sress ulcer bleeding in high risk patients. comparison of three drugs. Crit Care Med, 27(12), 1999 [A145].
26. Fabian, T.C., Boucher, B.A., Croce, M.A., Kuhl, D.A., Janning, S.W., Coffey, B.C., et al. Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 128:2 (1993), 185–191 [discussion 91–2].
27. Harlaftis, N., Basdanis, G., Papapolychroniadis, C., Prousalidis, J., Apostolidis, S., Kosmidis, C., et al. Nosocomial pneumonia in mechanically ventilated patients during stress ulcer prophylaxis with sucralfate and ranitidine. Hell J Gastroenterol 10 (1997), 230–235.
28. Kantorova, I., Svoboda, P., Scheer, P., Doubek, J., Rehorkova, D., Bosakova, H., et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 51:57 (2004), 757–761.
29. Laggner, A.N., Lenz, K., Graninger, W., Gremmel, F., Grimm, G., Base, W., et al. Prevention of stress hemorrhage in an internal medicine intensive care station: sucralfate versus ranitidine. Anaesthesist 37:11 (1988), 704–710.
30. Laggner, A.N., Lenz, K., Base, W., Druml, W., Schneeweiss, B., Grimm, G., Prevention of upper gastrointestinal bleeding in long-term ventilated patients: sucralfate versus ranitidine. Am J Med 86:6 (1989), 81–84.
31. Misra, U.K., Kalita, J., Pandey, S., Mandal, S.K., Srivastava, M., A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci 239:1 (2005), 5–10.
32. Mustafa, N.A., Aktürk, G., Özen, I., Köksal, I., Erciyes, N., Solak, M., Acute stress bleeding prophylaxis with sucralfate versus ranitidine and incidence of secondary pneumonia in intensive care unit patients. Intensiv Care Med, 21(3), 1995, 287.
33. Pickworth, K.K., Falcone, R.E., Hoogeboom, J.E., Santanello, S.A., Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: a comparison of sucralfate and ranitidine. Crit Care Med 21:12 (1993), 1856–1862.
34. Prakash, S., Rai, A., Gogia, A.R., Prakash, S., Nosocomial pneumonia in mechanically ventilated patients receiving ranitidine or sucralfate as stress ulcer prophylaxis. Indian J Anaesth, 52(2), 2008, 179.
35. Prod'hom, G., Leuenberger, P., Koerfer, J., Blum, A., Chiolero, R., Schaller, M.-D., et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 120:8 (1994), 653–662.
36. Ruiz-Santana, S., Ortiz, E., Gonzalez, B., Bolaños, J., Ruiz-Santana, A.J., Manzano, J.L., Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: frequency, complications, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med 19:7 (1991), 887–891.
37. Ryan, P., Dawson, J., Teres, D., Celoria, G., Navab, F., Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. Arch Surg 128:12 (1993), 1353–1357.
38. Simms, H.H., DeMaria, E., McDonald, L., Peterson, D., Robinson, A., Burchard, K.W., Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial. J Trauma 31:4 (1991), 531–536 [discussion 6–7].
39. Thomason, M.H., Payseur, E.S., Hakenewerth, A.M., Norton, H.J., Mehta, B., Reeves, T.R., et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma 41:3 (1996), 503–508.
40. Tryba, M., Zevounou, F., Torok, M., Zenz, M., Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine: a controlled study with pirenzepine as a basic medication. Am J Med 79:2 (1985), 55–61.
41. Cook, D.J., Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis. Scand J Gastroenterol Suppl 210 (1995), 48–52.
42. He, H., Hu, S., Chen, Q., Liu, L., Huang, Y., Yang, Y., et al. Effects of sucralfate and acid-suppressive drugs on preventing ventilator-associated pneumonia of mechanically ventilated patients: a meta-analysis. Zhonghua Nei Ke Za Zhi 53:1 (2014), 48–54.
43. Eom, C.-S., Jeon, C.Y., Lim, J.-W., Cho, E.-G., Park, S.M., Lee, K.-S., Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ 183:3 (2011), 310–319.
44. Morris, D.L., Youngs, D., Burdon, D.W., Keighley, M.R.B., The influence of sucralfate or cimetidine on gastric juice pH, bacterial flora and mutagenicity. Dig Surg 1:1 (1984), 6–9.
45. Tryba, M., Mantey-Stiers, F., Antibacterial activity of sucralfate in human gastric juice. Am J Med 83:3 (1987), 125–127.
46. West, A.P., Abdul, S., Sherratt, M.J., Inglis, T.J., Antibacterial activity of sucralfate against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa in batch and continuous culture. Eur J Clin Microbiol Infect Dis 12:11 (1993), 869–871.
47. Welage, L., Carver, P., Welch, K., Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid. Eur J Clin Microbiol Infect Dis 13:12 (1994), 1046–1052.
48. Resar, R., Pronovost, P., Haraden, C., Simmonds, T., Rainey, T., Nolan, T., Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 31:5 (2005), 243–248.